Study of a novel extra-corporeal treatment for the treatment of critically ill patients. This work includes both and observational component (focused on patients with COVID-19) and a randomized controlled trial component (patients with pathogen-associated shock).
|Effective start/end date||1/10/20 → 30/09/23|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.